

| Assistant Member T-Cell Epitope & Drug Discovery |
![]() |
858.597.3869 - phone 858.597.3804 - fax This e-mail address is being protected from spambots. You need JavaScript enabled to view it |
The main focus of my research is the discovery of novel immunological modulators and the understanding of their mechanisms in the regulation of the immune response. Our work includes the identification of novel antigens involved in the activation of autoimmune and anti-tumoral T cells, the identification of non-peptide molecules to control disease pathways and the identification of proteins from human pathogens that could improve diagnostics and treatment of infectious diseases. Current projects involve: 1- the identification and characterization of Trypanosoma cruzi antigens recognized by human recombinant antibodies derived from patients with Chagas disease, a prominent human health problem in Central and South America and 2- the evaluation of tumor antigens as tools to trigger therapeutic immune responses in cancer. Importantly, our research takes advantage of the great collection of synthetic combinatorial libraries designed and synthesized here at Torrey Pines. A number of our projects involve collaborations with scientists in the United States, Europe and South America and are developed closely with my long and outstanding collaborator in this area, Dr. Clemencia Pinilla, here at Torrey Pines.
Dr. Valeria A. Judkowski received a Master of Science in Molecular Biology from the “Universidad de Ciencias Exactas y Naturales de Buenos Aires”,
2008 - Present: Assistant Member, Torrey Pines Institute for Molecular Studies,
2002 - 2004: Postdoctoral Fellow, The Scripps Research Institute,
1998-2002: Predoctoral fellow, The Torrey Pines Institute for Molecular Studies,
2009 - Present:The American Association of Immunologists
1998: Award granted by “Fundación de la Hemofilia”. A large proportion of hemophilic patients transfused with clotting factor concentrates between 1978 and 1984 became infected with different viruses. The